Balance Sheet ANI Pharmaceuticals, Inc.

Stocks

ANIP

US00182C1036

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 08/06/2026 BST			5-day change	1st Jan Change
80.13 ^USD	-1.21%		+2.06%	+1.51%

05-29	ANI Pharmaceuticals Inc Recalls Estradiol Gel, 0.1%, 0.25 Mg (0.25 G Per Packet)	CI
05-14	Ani Pharmaceuticals Insider Sold Shares Worth $1,127,120, According to a Recent SEC Filing	MT

550e51cc81.aQKnqk3DlLG02-Q6ayJAMzMtRpxHKgmgx2rTWATQBmo.IVvN2Qjz2_nYrKIJP3N5WwJMKtJwH1bV9yHqAnegdDsBQfTBFZXl04OB1A

Published financial data: ANI PHARMACEUTICALS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	216M	316M	487M	614M	883M
Total Revenues	216M	316M	487M	614M	883M
Cost of Goods Sold, Total	98.71M	139M	182M	250M	341M
Gross Profit	117M	178M	305M	364M	542M
Selling General & Admin Expenses, Total	74.89M	124M	162M	237M	316M
R&D Expenses	7.57M	22.32M	34.29M	44.58M	51.66M
Depreciation & Amortization - (IS)	47.25M	56.97M	59.79M	67.73M	91.42M
Other Operating Expenses	780K	-	-	-	-
Other Operating Expenses, Total	130M	203M	256M	350M	459M
Operating Income	-13.07M	-25.73M	49.53M	14.62M	83.33M
Interest Expense, Total	-16.74M	-30.72M	-35.07M	-33.14M	-32.18M
Interest And Investment Income	4.82M	2.67M	8.13M	15.53M	12.12M
Net Interest Expenses	-11.92M	-28.05M	-26.94M	-17.6M	-20.06M
Currency Exchange Gains (Loss)	-	-	-	-	1.93M
Other Non Operating Income (Expenses)	-507K	-80K	-159K	-4.03M	-
EBT, Excl. Unusual Items	-25.5M	-53.87M	22.43M	-7.02M	65.2M
Restructuring Charges	-	-5.68M	-1.13M	-	-
Merger & Related Restructuring Charges	-9.4M	-	-	-12.4M	-2.1M
Gain (Loss) On Sale Of Investments	-	-	-	6.31M	2.82M
Gain (Loss) On Sale Of Assets	1.82M	750K	-	5.35M	-382K
Asset Writedown	-2.37M	-112K	-	-7.6M	-767K
Legal Settlements	-8.75M	-	-	-	-
Other Unusual Items	-11.86M	-3.76M	-1.43M	-6.85M	31.01M
EBT, Incl. Unusual Items	-56.06M	-62.66M	19.87M	-22.21M	95.79M
Income Tax Expense	-13.46M	-14.77M	1.09M	-3.69M	17.45M
Earnings From Continuing Operations	-42.6M	-47.9M	18.78M	-18.52M	78.34M
Net Income to Company	-42.6M	-47.9M	18.78M	-18.52M	78.34M
Net Income - (IS)	-42.6M	-47.9M	18.78M	-18.52M	78.34M
Preferred Dividend and Other Adjustments	190K	1.62M	3.3M	1.62M	8.12M
Net Income to Common Incl Extra Items	-42.79M	-49.52M	15.48M	-20.15M	70.22M
Net Income to Common Excl. Extra Items	-42.79M	-49.52M	15.48M	-20.15M	70.22M
Per Share Items
Net EPS - Basic	-3.4	-3.05	0.86	-1.04	3.5
Basic EPS - Continuing Operations	-3.4	-3.05	0.86	-1.04	3.5
Basic Weighted Average Shares Outstanding	12.6M	16.26M	18M	19.32M	20.05M
Net EPS - Diluted	-3.4	-3.05	0.85	-1.04	3.32
Diluted EPS - Continuing Operations	-3.4	-3.05	0.85	-1.04	3.32
Diluted Weighted Average Shares Outstanding	12.6M	16.26M	18.19M	19.32M	21.23M
Normalized Basic EPS	-1.27	-2.07	0.78	-0.23	2.03
Normalized Diluted EPS	-1.27	-2.07	0.77	-0.23	1.92
Payout Ratio	-0.45	-3.39	8.65	-8.77	1.48
Supplemental Items
EBITDA	34.18M	33.92M	109M	82.35M	175M
EBITA	28.73M	23.77M	102M	74.92M	166M
EBIT	-13.07M	-25.73M	49.53M	14.62M	83.33M
EBITDAR	34.47M	34.86M	112M	84.78M	178M
Effective Tax Rate - (Ratio)	24	23.57	5.5	16.61	18.22
Current Domestic Taxes	2.62M	401K	12.65M	15.94M	2.52M
Current Foreign Taxes	691K	66K	26K	1.88M	171K
Total Current Taxes	3.31M	467K	12.68M	17.82M	2.69M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-16.76M	-15.24M	-11.58M	-21.51M	14.76M
Normalized Net Income	-15.94M	-33.67M	14.02M	-4.39M	40.75M
Interest Capitalized	98K	95K	587K	492K	381K
Interest on Long-Term Debt	12.04M	28.51M	33.06M	51.75M	32.56M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	11.37M	22.32M	34.29M	48.58M	51.66M
Net Rental Expense, Total	288K	937K	2.25M	2.43M	3.55M
Imputed Operating Lease Interest Expense	157K	802K	2.22M	1.42M	1.48M
Imputed Operating Lease Depreciation	131K	135K	34.01K	1M	2.07M
Stock-Based Comp., COGS (Total)	20K	532K	706K	1.28M	1.8M
Stock-Based Comp., R&D Exp. (Total)	564K	751K	910K	1.53M	2.14M
Stock-Based Comp., SG&A Exp. (Total)	9.9M	13.32M	19.04M	26.53M	33.98M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	10.49M	14.6M	20.65M	29.34M	37.93M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	100M	48.23M	221M	145M	286M
Short Term Investments	-	-	-	6.31M	9.13M
Total Cash And Short Term Investments	100M	48.23M	221M	151M	295M
Accounts Receivable, Total	129M	165M	162M	222M	281M
Total Receivables	129M	165M	162M	222M	281M
Inventory	81.69M	105M	111M	137M	143M
Prepaid Expenses	7.39M	8.09M	17.2M	17.78M	22.99M
Restricted Cash	-	5.01M	-	33K	36K
Other Current Assets, Total	3.87M	12.15M	8.22M	200K	11.23M
Total Current Assets	322M	344M	520M	528M	753M
Gross Property Plant And Equipment	75.63M	75.96M	77.53M	102M	115M
Accumulated Depreciation	-22.96M	-32.71M	-32.94M	-44.88M	-52.69M
Net Property Plant And Equipment	52.67M	43.25M	44.59M	56.86M	62.48M
Long-term Investments	-	8.8M	6.2M	4.9M	1.65M
Goodwill	27.89M	28.22M	28.22M	59.99M	62.48M
Other Intangibles, Total	294M	252M	209M	542M	480M
Deferred Tax Assets Long-Term	67.94M	81.36M	90.71M	85.11M	69.07M
Deferred Charges Long-Term	800K	600K	400K	900K	600K
Other Long-Term Assets, Total	6.41M	1.96M	5.47M	6.42M	11.46M
Total Assets	772M	760M	904M	1.28B	1.44B
Liabilities
Accounts Payable, Total	22.97M	29.3M	36.68M	45.66M	62.58M
Accrued Expenses, Total	27.42M	35.2M	56.28M	90.76M	144M
Current Portion of Long-Term Debt	850K	850K	850K	9.17M	17.27M
Current Portion of Leases	387K	684K	1.56M	2.04M	2.03M
Current Income Taxes Payable	-	-	8.16M	6.75M	2.24M
Unearned Revenue Current, Total	87K	-	-	-	-
Other Current Liabilities	35.83M	33.4M	41.94M	39.3M	49.67M
Total Current Liabilities	87.54M	99.44M	145M	194M	278M
Long-Term Debt	293M	286M	285M	615M	600M
Long-Term Leases	995K	1.38M	4.11M	4.55M	9.22M
Other Non Current Liabilities	31.02M	35.06M	12.42M	42.02M	12.55M
Total Liabilities	413M	422M	447M	855M	900M
Preferred Stock Convertible	24.85M	24.85M	24.85M	24.85M	-
Total Preferred Equity	24.85M	24.85M	24.85M	24.85M	-
Common Stock, Total	1K	1K	2K	2K	3K
Additional Paid In Capital	388M	404M	514M	520M	596M
Retained Earnings	-47.76M	-97.29M	-80.13M	-100M	-23.1M
Treasury Stock	-3.14M	-5.09M	-10.08M	-21.04M	-33.25M
Comprehensive Income and Other	-3.06M	12.17M	8.86M	5.34M	1.03M
Total Common Equity	334M	314M	433M	404M	541M
Total Equity	359M	339M	458M	429M	541M
Total Liabilities And Equity	772M	760M	904M	1.28B	1.44B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	16.55M	16.35M	19.72M	20.31M	20.88M
ECS Total Common Shares Outstanding	16.12M	16.35M	19.12M	19.65M	20.95M
Book Value / Share	20.71	19.18	22.64	20.54	25.8
Tangible Book Value	11.88M	33.83M	196M	-198M	-1.28M
Tangible Book Value Per Share	0.74	2.07	10.23	-10.08	-0.06
Total Debt	296M	289M	291M	631M	628M
Net Debt	195M	240M	70.22M	480M	334M
Debt Equivalent Oper. Leases	2.3M	7.5M	18.02M	19.41M	28.38M
Account Code - Inventory Valuation	3	6	6	6	6
Inventories - Raw Materials, Total	56.82M	78.26M	71.85M	77.15M	84.11M
Inventories - Work In Process, Total	652K	1.89M	3.14M	1.66M	2.97M
Inventories - Finished Goods, Total	31.97M	35.49M	36.2M	57.97M	55.99M
Land - (BS)	5.95M	1.55M	1.55M	1.58M	2.41M
Buildings, Total	19.97M	16.66M	17.88M	24.44M	25.83M
Machinery, Total	46.77M	53.15M	50.41M	68.7M	76.04M
Full Time Employees	601	600	642	897	970
Order Backlog	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-42.6M	-47.9M	18.78M	-18.52M	78.34M
Depreciation & Amortization - CF	5.45M	10.15M	7.49M	7.43M	8.92M
Amortization of Goodwill and Intangible Assets - (CF)	41.8M	49.5M	52.3M	60.3M	82.5M
Depreciation & Amortization, Total	47.25M	59.65M	59.79M	67.73M	91.42M
(Gain) Loss From Sale Of Asset	-1.82M	-750K	-	-5.35M	382K
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-6.31M	-2.82M
Asset Writedown & Restructuring Costs	2.37M	1.72M	-	7.6M	767K
Stock-Based Compensation (CF)	10.49M	14.6M	20.65M	29.34M	37.93M
Other Operating Activities, Total	-12.28M	-7.23M	-5.12M	703K	-13.66M
Change In Accounts Receivable	-5.55M	-36.91M	3.36M	-21.09M	-58.53M
Change In Inventories	3.22M	-23.63M	-5.84M	-21.29M	-5.96M
Change In Accounts Payable	10.17M	5.04M	7.55M	479K	15.16M
Change In Income Taxes	-7.57M	-160K	11.99M	-1.42M	-15.53M
Change in Other Net Operating Assets	-353K	4.36M	7.8M	32.12M	57.74M
Cash from Operations	3.32M	-31.2M	119M	64.02M	185M
Capital Expenditure	-2.56M	-8.88M	-8.87M	-16.24M	-13.84M
Sale of Property, Plant, and Equipment	2.65M	750K	-	13.51M	-
Cash Acquisitions	-84.49M	-33K	-	-401M	-
Sale (Purchase) of Intangible assets	-21.08M	-7.58M	-9.64M	-717K	-20.49M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-105M	-15.74M	-18.51M	-405M	-34.32M
Long-Term Debt Issued, Total	324M	-	-	641M	-
Total Debt Issued	324M	-	-	641M	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-211M	-3M	-3M	-296M	-10.16M
Total Debt Repaid	-211M	-3M	-3M	-296M	-10.16M
Issuance of Common Stock	77.07M	1.46M	89.55M	6.49M	13.6M
Repurchase of Common Stock	-890K	-1.96M	-4.99M	-10.96M	-12.21M
Issuance of Preferred Stock	25M	-	-	-	-
Preferred Dividends Paid	-190K	-1.62M	-1.62M	-1.62M	-1.16M
Common & Preferred Stock Dividends Paid	-190K	-1.62M	-1.62M	-1.62M	-1.16M
Other Financing Activities, Total	-19.38M	-	-12.5M	-74.18M	-26K
Cash from Financing	195M	-5.13M	67.44M	265M	-9.94M
Foreign Exchange Rate Adjustments	-	-	-	-470K	-233K
Net Change in Cash	92.43M	-52.07M	168M	-76.23M	141M
Supplemental Items
Cash Interest Paid	9.7M	21.48M	31.43M	24.38M	26.93M
Cash Income Tax Paid (Refund)	10.37M	288K	1.23M	19.06M	17.67M
Levered Free Cash Flow	-22.57M	-40.83M	113M	28.57M	119M
Unlevered Free Cash Flow	-12.11M	-21.63M	135M	49.28M	140M
Change In Net Working Capital	38.04M	63.34M	-41.82M	39.98M	7.58M
Net Debt Issued / Repaid	113M	-3M	-3M	345M	-10.16M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-1.33	-2.1	3.72	0.84	3.82
Return on Total Capital	-1.56	-2.53	4.5	1.01	4.69
Return On Equity %	-15.37	-13.74	4.72	-4.18	16.16
Return on Common Equity	-16.16	-15.29	4.15	-4.82	14.87
Margin Analysis
Gross Profit Margin %	54.33	56.13	62.71	59.27	61.36
SG&A Margin	34.65	39.21	33.22	38.61	35.73
EBITDA Margin %	15.82	10.72	22.46	13.4	19.78
EBITA Margin %	13.29	7.51	20.92	12.19	18.77
EBIT Margin %	-6.05	-8.13	10.17	2.38	9.43
Income From Continuing Operations Margin %	-19.71	-15.14	3.86	-3.01	8.87
Net Income Margin %	-19.71	-15.14	3.86	-3.01	8.87
Net Avail. For Common Margin %	-19.8	-15.65	3.18	-3.28	7.95
Normalized Net Income Margin	-7.37	-10.64	2.88	-0.71	4.61
Levered Free Cash Flow Margin	-10.44	-12.9	23.17	4.65	13.52
Unlevered Free Cash Flow Margin	-5.6	-6.84	27.67	8.02	15.8
Asset Turnover
Asset Turnover	0.35	0.41	0.58	0.56	0.65
Fixed Assets Turnover	4.6	6.6	11.08	12.11	14.8
Receivables Turnover (Average Receivables)	1.93	2.15	2.97	3.2	3.51
Inventory Turnover (Average Inventory)	1.39	1.48	1.68	2.02	2.44
Short Term Liquidity
Current Ratio	3.68	3.46	3.57	2.72	2.71
Quick Ratio	2.61	2.15	2.63	1.93	2.07
Operating Cash Flow to Current Liabilities	0.04	-0.31	0.82	0.33	0.67
Days Sales Outstanding (Average Receivables)	189.41	169.57	122.78	114.32	103.88
Days Outstanding Inventory (Average Inventory)	263.45	245.96	217.73	181.37	149.64
Average Days Payable Outstanding	52.23	58.72	64.28	54.63	56.83
Cash Conversion Cycle (Average Days)	400.63	356.81	276.23	241.05	196.68
Long Term Solvency
Total Debt/Equity	82.38	85.24	63.67	147.17	116.19
Total Debt / Total Capital	45.17	46.02	38.9	59.54	53.74
LT Debt/Equity	82.04	84.79	63.14	144.56	112.62
Long-Term Debt / Total Capital	44.98	45.77	38.58	58.48	52.09
Total Liabilities / Total Assets	53.51	55.46	49.4	66.62	62.46
EBIT / Interest Expense	-0.78	-0.84	1.41	0.44	2.59
EBITDA / Interest Expense	2.06	1.13	3.18	2.56	5.54
(EBITDA - Capex) / Interest Expense	1.91	0.85	2.93	2.07	5.11
Total Debt / EBITDA	8.57	8.28	2.61	7.44	3.52
Net Debt / EBITDA	5.66	6.9	0.63	5.66	1.87
Total Debt / (EBITDA - Capex)	9.26	11.11	2.84	9.2	3.82
Net Debt / (EBITDA - Capex)	6.12	9.25	0.68	7	2.03
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.67	46.38	53.87	26.2	43.78
Gross Profit, 1 Yr. Growth %	-3.21	53.73	66.92	19.28	43.49
EBITDA, 1 Yr. Growth %	-3.89	19.08	124.85	-24.67	71.91
EBITA, 1 Yr. Growth %	-6.81	3.19	164.72	-26.43	76.01
EBIT, 1 Yr. Growth %	44.09	37.11	-548.88	-70.49	145.68
Earnings From Cont. Operations, 1 Yr. Growth %	88.94	12.42	-139.21	-198.63	-522.94
Net Income, 1 Yr. Growth %	88.94	12.42	-139.21	-198.63	-522.94
Normalized Net Income, 1 Yr. Growth %	34.09	72.66	-157.27	-131.28	430.85
Diluted EPS Before Extra, 1 Yr. Growth %	80.4	-10.29	-127.92	-222.49	-418.75
Accounts Receivable, 1 Yr. Growth %	34.17	28.72	-2.03	36.8	26.77
Inventory, 1 Yr. Growth %	34.36	28.96	5.54	23.01	4.59
Net Property, Plant and Equip., 1 Yr. Growth %	27.63	-17.89	3.11	27.52	9.87
Total Assets, 1 Yr. Growth %	67.31	-1.49	18.99	41.94	12.14
Tangible Book Value, 1 Yr. Growth %	229.18	184.8	477.88	-201.34	-99.35
Common Equity, 1 Yr. Growth %	70.61	-6.05	37.95	-6.72	33.95
Cash From Operations, 1 Yr. Growth %	-78.24	-1.04K	-481.24	-46.19	189.34
Capital Expenditures, 1 Yr. Growth %	-58.32	247.13	-0.09	83.09	-14.79
Levered Free Cash Flow, 1 Yr. Growth %	-53.26	58.57	-464.36	-75.02	179.86
Unlevered Free Cash Flow, 1 Yr. Growth %	-69.68	41.53	-1.25K	-63.84	120.15
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.29	23.19	50.08	39.35	34.71
Gross Profit, 2 Yr. CAGR %	-9.51	20.99	62.56	43.2	33.25
EBITDA, 2 Yr. CAGR %	-25.16	8.02	139.35	55.81	26.43
EBITA, 2 Yr. CAGR %	-28.77	-1.17	173.32	77.55	27.61
EBIT, 2 Yr. CAGR %	-10.8	28.56	32.6	-24.63	29.71
Earnings From Cont. Operations, 2 Yr. CAGR %	164.4	45.75	-33.61	-37.81	104.24
Net Income, 2 Yr. CAGR %	164.4	45.75	-33.61	-37.81	104.24
Normalized Net Income, 2 Yr. CAGR %	180.88	45.3	-29.24	-63.65	70.5
Diluted EPS Before Extra, 2 Yr. CAGR %	160.77	27.21	-49.96	-41.52	97.6
Accounts Receivable, 2 Yr. CAGR %	33.49	31.42	12.3	15.77	31.69
Inventory, 2 Yr. CAGR %	30.24	31.63	16.67	13.94	13.43
Net Property, Plant and Equip., 2 Yr. CAGR %	13.97	2.37	-7.99	14.67	18.36
Total Assets, 2 Yr. CAGR %	29.97	28.38	8.27	29.96	26.2
Tangible Book Value, 2 Yr. CAGR %	-35.8	206.18	305.68	142	-91.9
Common Equity, 2 Yr. CAGR %	25.26	26.61	13.85	13.44	11.78
Cash From Operations, 2 Yr. CAGR %	-73.02	42.96	498.41	43.24	24.78
Capital Expenditures, 2 Yr. CAGR %	-37.92	20.28	86.23	35.25	24.9
Levered Free Cash Flow, 2 Yr. CAGR %	24.59	-9.56	98.51	-14.08	2.19
Unlevered Free Cash Flow, 2 Yr. CAGR %	-27.39	-29.88	152.33	53.4	1.19
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.35	15.27	32.67	41.66	40.81
Gross Profit, 3 Yr. CAGR %	-2.97	7.39	36.02	46.62	45.06
EBITDA, 3 Yr. CAGR %	-20.91	-17.79	55.51	62.81	72.71
EBITA, 3 Yr. CAGR %	-24.61	-25.13	61.15	76.48	91.09
EBIT, 3 Yr. CAGR %	-28.23	16.14	47.07	-19.64	47.94
Earnings From Cont. Operations, 3 Yr. CAGR %	40.1	98.82	-5.91	-24.24	17.82
Net Income, 3 Yr. CAGR %	40.1	98.82	-5.91	-24.24	17.82
Normalized Net Income, 3 Yr. CAGR %	8.34	155.44	-4.21	-46.09	7.07
Diluted EPS Before Extra, 3 Yr. CAGR %	37.78	82.72	-23.27	-32.56	2.91
Accounts Receivable, 3 Yr. CAGR %	25.62	31.88	19.16	19.93	19.33
Inventory, 3 Yr. CAGR %	26.35	29.81	22.29	18.74	10.74
Net Property, Plant and Equip., 3 Yr. CAGR %	11.41	2.17	2.62	2.59	13.05
Total Assets, 3 Yr. CAGR %	21.46	18.5	25.17	18.49	23.75
Tangible Book Value, 3 Yr. CAGR %	14.47	5.49	278.39	155.5	-66.41
Common Equity, 3 Yr. CAGR %	19.18	13.81	30.28	6.53	19.9
Cash From Operations, 3 Yr. CAGR %	-63.28	-11.9	98.25	168.1	81.06
Capital Expenditures, 3 Yr. CAGR %	-23.64	10.19	13.07	85.18	15.95
Levered Free Cash Flow, 3 Yr. CAGR %	-21.66	41.08	31.23	-0.06	45.58
Unlevered Free Cash Flow, 3 Yr. CAGR %	-40.08	-1.97	45.22	32.56	88.17
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.94	12.34	19.28	24.36	33.48
Gross Profit, 5 Yr. CAGR %	6.49	12.67	18.89	20.49	34.9
EBITDA, 5 Yr. CAGR %	-9.5	-9.91	9.61	6.17	43.15
EBITA, 5 Yr. CAGR %	-12.29	-15.73	8.71	5.76	46.79
EBIT, 5 Yr. CAGR %	-17.39	-2.52	6.97	-2.31	39.86
Earnings From Cont. Operations, 5 Yr. CAGR %	61.04	113.65	3.92	24.9	28.28
Net Income, 5 Yr. CAGR %	61.04	113.65	3.92	24.9	28.28
Normalized Net Income, 5 Yr. CAGR %	2.48	25.57	2.27	16.77	20.64
Diluted EPS Before Extra, 5 Yr. CAGR %	58.49	100.91	-8.12	15.84	12.02
Accounts Receivable, 5 Yr. CAGR %	22.87	22.99	20.11	25.18	24.02
Inventory, 5 Yr. CAGR %	25.55	22.8	22.38	23.21	18.67
Net Property, Plant and Equip., 5 Yr. CAGR %	36.79	16.21	3.2	7	8.65
Total Assets, 5 Yr. CAGR %	19.03	13.02	16	22.96	25.58
Tangible Book Value, 5 Yr. CAGR %	8.28	-9.87	89.88	47.04	-18.7
Common Equity, 5 Yr. CAGR %	14.5	12.41	17.01	13.66	22.54
Cash From Operations, 5 Yr. CAGR %	-34.46	-4.57	12.14	7.01	64.74
Capital Expenditures, 5 Yr. CAGR %	-10.95	-3.06	9.08	19.6	17.66
Levered Free Cash Flow, 5 Yr. CAGR %	-28.88	-13.37	19.16	14.46	19.06
Unlevered Free Cash Flow, 5 Yr. CAGR %	-36.47	-22.35	19.08	16.51	25.97